iRobot has announced that its RP-VITA autonomous remote presence robot, co-developed by InTouch Health, has received clearance from the U.S. Food and Drug Administration (FDA) for use in hospitals.
RP-VITA was developed as part of a suite of remote presence medical robots by iRobot and InTouch Health. The robot provides the usual telemedicine remote presence functions, such as an audio/visual connection between the patient and the doctor in a form factor that suggests something of actual presence. It also enables smooth communication with hospital staff and access to medical chart information.
UPGRADE TO NEW ATLAS PLUS
More than 1,200 New Atlas Plus subscribers directly support our journalism, and get access to our premium ad-free site and email newsletter. Join them for just US$19 a year.UPGRADE
The most remarkable ability of the RP-VITA, however, is that it can proceed from point to point in the hospital autonomously. The designers realized that they should not waste the time of either the physician or the hospital staff in guiding the robot around the hospital – that would rather defeat the goal of using the time of live people efficiently. RP-VITA was given the ability to move around the busy halls of a hospital by itself.
The robot knows the layout of the hospital, keeps track of its own location, and uses an array of sophisticated sensors and programming to autonomously move about a busy space without interfering with people or other objects. The doctor need only click on the location of the next patient to visit, and RP-VITA signals when it has arrived on site. The video at the bottom of the page shows RP-VITA making its way around a hospital.
The FDA clearance specifies that RP-VITA can be used for active patient monitoring in non-surgical patients, and before, during, and after surgical care. It can also be used in testing patients, including cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations.
The RP-VITA was not evaluated for performing operations remotely, at least partially because it has no hands or other manipulating appendages. However, iRobot and InTouch Health are developing a similar unit which has extendable pan, tilt, and zoom lenses designed so that a remote surgeon can collaborate with, or guide and mentor, an on-site surgeon. These functions have not yet been evaluated by the FDA.
“FDA clearance of a robot that can move safely and independently through a fast-paced, chaotic and demanding hospital environment is a significant technological milestone for the robotics and healthcare industries,” said Colin Angle, chairman and CEO of iRobot. “There are very few environments as difficult to maneuver as that of a busy ICU or emergency department. Having crossed this technology threshold, the potential for self-navigating robots in other markets, and for new applications, is virtually limitless.”